Klinic
Klinic is a platform designed to help independent healthcare practitioners launch, run, and grow their private practices. They offer a comprehensive suite of services, including technology integration (EHR, e-Rx, patient portal, CRM), marketing automation, patient acquisition and retention strategies, and administrative support such as billing, credentialing, and payor compliance. Klinic aims to reduce provider burnout and improve patient access to care for chronic conditions like addiction, depression, and obesity. The company serves millions of people struggling with these conditions by facilitating access to emerging treatments through its network of independent practitioners.
Klinic
Klinic is a platform designed to help independent healthcare practitioners launch, run, and grow their private practices. They offer a comprehensive suite of services, including technology integration (EHR, e-Rx, patient portal, CRM), marketing automation, patient acquisition and retention strategies, and administrative support such as billing, credentialing, and payor compliance. Klinic aims to reduce provider burnout and improve patient access to care for chronic conditions like addiction, depression, and obesity. The company serves millions of people struggling with these conditions by facilitating access to emerging treatments through its network of independent practitioners.
TL;DR
What they do: Practice-in-a-box platform helping independent healthcare practitioners launch, run, and grow private practices
Target areas: Chronic conditions including addiction, depression, and obesity; mental health and primary care workflows
Headquarters: Seattle, Washington, United States
Founding year: 2021
Reported investors: I2BF Global Ventures; Liquid 2 Ventures; Wicklow Capital; Ross Lipson
Company Overview
Problem Domain
Provider burnout, fragmented practice operations, and limited patient access for chronic and mental health conditions
Founded
2021
Industry
Healthtech / Healthcare
Funding Track Record
Public profiles list two funding rounds with obfuscated/withheld amounts and dates
Investor Signal
“Backed by early-stage investors including I2BF Global Ventures, Liquid 2 Ventures, Wicklow Capital, and Ross Lipson”